SEPTICEMIA IN PATIENTS WITH HEMATOLOGICAL DISORDERS AND NEUTROPENIA - A RETROSPECTIVE STUDY OF CAUSATIVE AGENTS AND THEIR RESISTANCE PROFILE

被引:31
作者
GUNTHER, G
BJORKHOLM, M
BJORKLIND, A
ENGERVALL, P
STIERNSTEDT, G
机构
[1] DANDERYD HOSP, DEPT MED, DIV HEMATOL, S-18288 DANDERYD, SWEDEN
[2] KAROLINSKA INST, KAROLINSKA HOSP, DEPT MED, DIV HEMATOL & IMMUNOL, S-10401 STOCKHOLM 60, SWEDEN
[3] KAROLINSKA INST, KAROLINSKA HOSP, DEPT CLIN BACTERIOL, S-10401 STOCKHOLM 60, SWEDEN
关键词
D O I
10.3109/00365549109105183
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In order to identify the cause of septicemia and the resistance patterns of bacteria in Swedish patients with hematological disorders, all positive blood cultures collected at a hematological ward during 1980-1986 were evaluated retrospectively. 198 episodes of septicemia in 129 patients were recorded. 54% were males and 46% women with a median age of 67 years (range 16-88). Patients with acute leukemia (46%), lymphoma (19%) and myeloma (19%) dominated. The absolute neutrophil count (ANC) was < 0.5 x 10(9)/l in 76% of the bacteremic episodes. A total of 253 consecutive isolates were found with 53% Gram-negatives and 47% Gram-positives. The dominating pathogens were Escherichia coli (27%), klebsiella/enterobacter (15%), pseudomonas (7%), coagulase negative staphylococci (13%), alpha-streptococci (13%), Staphylococcus aureus (10%) and anaerobes (6%). Coagulase negative staphylococci showed a significant increase in isolation rate during the study period. The majority of E. coli were resistant to ampicillin. The susceptibility of klebsiella/enterobacter to ceftazidime and cefuroxime was reduced, while no imipenem resistant strains occurred. Among coagulase negative staphylococci 61% were resistant to isoxazolylpenicillin, none to vancomycin. No dramatic changes in the etiology of septicemia or the susceptibility pattern during the study period were noticed. Coagulase negative staphylococci, S. epidermidis in particular, constitute an increasing problem among granulocytopenic patients.
引用
收藏
页码:589 / 598
页数:10
相关论文
共 35 条
[1]  
BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513
[2]   IMIPENEM CILASTATIN AS SECONDARY THERAPY FOR INFECTIONS IN CANCER-PATIENTS [J].
BODEY, GP ;
ROLSTON, K ;
JONES, P ;
ALVAREZ, ME ;
FAINSTEIN, V ;
STEELHAMMER, L .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 :161-166
[3]  
BODEY GP, 1978, CANCER, V41, P1610, DOI 10.1002/1097-0142(197804)41:4<1610::AID-CNCR2820410452>3.0.CO
[4]  
2-B
[5]   IMIPENEM-CILASTATIN AS INITIAL THERAPY FOR FEBRILE CANCER-PATIENTS [J].
BODEY, GP ;
ALVAREZ, ME ;
JONES, PG ;
ROLSTON, KVI ;
STEELHAMMER, L ;
FAINSTEIN, V .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (02) :211-214
[6]   QUANTITATIVE RELATIONSHIPS BETWEEN CIRCULATING LEUKOCYTES AND INFECTION IN PATIENTS WITH ACUTE LEUKEMIA [J].
BODEY, GP ;
BUCKLEY, M ;
SATHE, YS ;
FREIREICH, EJ .
ANNALS OF INTERNAL MEDICINE, 1966, 64 (02) :328-+
[7]   NEUTROPENIA, FEVER, AND INFECTION [J].
BROWN, AE .
AMERICAN JOURNAL OF MEDICINE, 1984, 76 (03) :421-428
[8]   BACTEREMIA AND CANDIDEMIA IN HEMATOLOGICAL MALIGNANCIES - MICROBIOLOGICAL FINDINGS AND ANTIBIOTIC SUSCEPTIBILITIES [J].
BRUUN, B ;
BANGSBORG, J ;
HOVGAARD, D ;
SKINHOJ, P .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1988, 20 (05) :503-509
[9]  
CALANDRA T, 1987, NEW ENGL J MED, V317, P1692
[10]   STOPPING ANTIBIOTIC-THERAPY IN NEUTROPENIC PATIENTS [J].
DINUBILE, MJ .
ANNALS OF INTERNAL MEDICINE, 1988, 108 (02) :289-292